Novasight™ Hybrid Imaging System Featured in Published JSCAI Case Report Demonstrating Superior Diagnosis and Precision-Guided Therapy in Complex Coronary Case

Core Insights - Conavi Medical Inc. announced the publication of a case report in the Journal of the Society for Cardiovascular Angiography & Interventions, showcasing the effectiveness of its Novasight™ Hybrid IVUS-OCT System in a complex coronary artery case [1][2] - The case report emphasizes the importance of hybrid imaging in accurately diagnosing plaque rupture, which was misidentified as calcification through traditional angiography [2][3] - The company is optimistic about the next-generation Novasight™ Hybrid System, which aims to enhance image quality and functionality, with FDA 510(k) submission expected in Q3 2025 [2] Company Overview - Conavi Medical focuses on designing, manufacturing, and marketing imaging technologies for minimally invasive cardiovascular procedures [12] - The Novasight Hybrid™ System is the first to combine intravascular ultrasound (IVUS) and optical coherence tomography (OCT) for simultaneous imaging of coronary arteries [12] - The system has received regulatory approvals from the U.S. FDA, Health Canada, China's National Medical Products Administration, and Japan's Ministry of Health, Labor and Welfare [12] Clinical Impact - The case report details the treatment of a 52-year-old male patient with multiple cardiovascular risk factors, where hybrid imaging revealed a plaque rupture instead of significant calcification [2][3] - The simultaneous use of IVUS and OCT allowed for precise identification and treatment of the lesion, demonstrating the transformative potential of hybrid imaging in interventional cardiology [3][8] - The publication aligns with new U.S. imaging Class 1A Guidelines advocating for broader use of intracoronary imaging in percutaneous coronary interventions (PCI) [3]